lncRNA Blog lncRNA Research and Industry News
Chemotherapy is a reasonable alternative to cystectomy in patients with invasive and advanced bladder cancer. However, bladder cancer cells often develop drug resistance to these therapies and approximately 50% of patients with advanced bladder cancer do not respond to chemotherapy. Recent studies show that long-noncoding RNA (lncRNA) is involved in the development of chemoresistance. Here researchers from the Shanghai Jiaotong ...
Read More »
Don't Miss
- LncTarD 2.0 – an updated comprehensive database for experimentally-supported functional lncRNA–target regulations in human diseases
- PhD and Postdoctoral Opportunities in Non-Coding RNA and Cancer Research
- Diabetes-causing gene can be regulated like a rheostat
- Emerging Non-Coding RNA Therapeutics Summit
- Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board
- New findings may contribute to better diagnosis and treatment of liver cancer
- Featured lncRNA Job – Scientist – RNA Biology
- lncRNA identified as potential new diagnostic and therapeutic target for lung cancer
- RNA molecules with no apparent function represent a new therapeutic approach against fungal infection by Candida
- RNAging: An exercise-regulated long noncoding RNA counteracts muscle aging